Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. GoodRx to offer Sanofi's insulin injection for only $35 - AOL

   www.aol.com/news/goodrx-offer-sanofis-insulin...

   This collaboration comes after Novo Nordisk , Eli Lilly and Sanofi pledged in March to lower the list prices of many of their insulin products by 70%-78% later in the year or in 2024. GoodRx to ...

3. Sanofi announces insulin price cap after actions by Eli ... - AOL

   www.aol.com/news/sanofi-announces-insulin-price...

   Sanofi will cap the out-of-pocket cost of its most popular insulin, Lantus, at $35 per month for people with private insurance, the French drugmaker said Thursday. The change will take effect Jan ...

4. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Largest selling pharmaceutical products of 2015 Drugs ... Insulin glargine: 685,461: 5.84%: Sanofi-Aventis: Diabetes mellitus type 1 and 2: Apr-2000: Dec-2011 16:

5. Sanofi to cut U.S. insulin costs for some patients to ... - AOL

   www.aol.com/news/sanofi-cut-u-insulin-costs...

   Sanofi SA said on Wednesday it will cut the cost of its insulin products to $99 per month for uninsured patients and others who pay cash for it in the United States, as the French drugmaker ...

6. Insulin glargine/lixisenatide - Wikipedia

   en.wikipedia.org/wiki/Insulin_glargine/lixisenatide

   Insulin glargine/lixisenatide, sold under the brand name Soliqua among others, is a fixed-dose combination medication that combines insulin glargine and lixisenatide and is used to treat diabetes . The most common side effects include hypoglycemia (low blood glucose), diarrhea, vomiting and nausea (feeling sick). [5]

7. Insulin (medication) - Wikipedia

   en.wikipedia.org/wiki/Insulin_(medication)

   As a medication, insulin is any pharmaceutical preparation of the protein hormone insulin that is used to treat high blood glucose. [6] Such conditions include type 1 diabetes, type 2 diabetes, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. [6]

8. Sanofi eyes German insulin investment of up to $1.6 ... - AOL

   www.aol.com/news/sanofi-eyes-german-insulin...

   French drugmaker Sanofi is nearing a decision to invest between 1.3 billion and 1.5 billion euros ($1.4-$1.6 billion) to upgrade its production of long-acting insulin shots in Germany, a person ...

9. Sanofi - Wikipedia

   en.wikipedia.org/wiki/Sanofi

   Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...